Recent Analysts’ Ratings Updates for Zoetis (ZTS)

Zoetis (NYSE: ZTS) recently received a number of ratings updates from brokerages and research firms:

• 2/14/2025 – Zoetis had its price target raised by analysts at Barclays PLC from $242.00 to $244.00. They now have an “overweight” rating on the stock.
• 2/14/2025 – Zoetis had its price target lowered by analysts at Morgan Stanley from $243.00 to $238.00. They now have an “overweight” rating on the stock.
• 2/10/2025 – Zoetis had its price target lowered by analysts at Piper Sandler from $210.00 to $200.00. They now have an “overweight” rating on the stock.
• 2/4/2025 – Zoetis was given a new $243.00 price target on by analysts at Morgan Stanley.
• 1/29/2025 – Zoetis had its price target lowered by analysts at Morgan Stanley from $248.00 to $243.00. They now have an “overweight” rating on the stock.
• 1/7/2025 – Zoetis had its price target lowered by analysts at Stifel Nicolaus from $210.00 to $180.00. They now have a “buy” rating on the stock.

Zoetis Trading Up 1.6 %

ZTS traded up $2.67 during trading on Tuesday, reaching $167.98. The company had a trading volume of 1,115,214 shares, compared to its average volume of 3,245,493. The company has a quick ratio of 1.08, a current ratio of 1.75 and a debt-to-equity ratio of 1.09. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $200.53. The stock has a market cap of $75.22 billion, a P/E ratio of 30.71, a PEG ratio of 2.78 and a beta of 0.90. The business has a 50 day simple moving average of $166.30 and a 200-day simple moving average of $177.78.

Zoetis (NYSE:ZTS) last announced its earnings results on Thursday, February 13th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.03. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. The business had revenue of $2.32 billion during the quarter, compared to analyst estimates of $2.30 billion. On average, equities analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Monday, April 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.19%. Zoetis’s dividend payout ratio is currently 36.56%.

Insider Activity at Zoetis

In other Zoetis news, EVP Roxanne Lagano sold 326 shares of the stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $171.18, for a total transaction of $55,804.68. Following the sale, the executive vice president now owns 16,107 shares of the company’s stock, valued at approximately $2,757,196.26. This trade represents a 1.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.16% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Zoetis

Several institutional investors and hedge funds have recently bought and sold shares of ZTS. Vanguard Group Inc. grew its holdings in shares of Zoetis by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 41,366,877 shares of the company’s stock valued at $6,739,905,000 after buying an additional 120,158 shares during the last quarter. State Street Corp lifted its position in Zoetis by 0.5% during the 3rd quarter. State Street Corp now owns 19,779,344 shares of the company’s stock worth $3,864,488,000 after acquiring an additional 95,856 shares during the period. Geode Capital Management LLC grew its stake in Zoetis by 1.8% during the 4th quarter. Geode Capital Management LLC now owns 10,617,897 shares of the company’s stock valued at $1,726,075,000 after purchasing an additional 190,137 shares during the last quarter. Polen Capital Management LLC increased its holdings in shares of Zoetis by 17.5% in the fourth quarter. Polen Capital Management LLC now owns 7,483,194 shares of the company’s stock valued at $1,219,237,000 after purchasing an additional 1,116,541 shares during the period. Finally, Wellington Management Group LLP increased its holdings in shares of Zoetis by 78.5% in the fourth quarter. Wellington Management Group LLP now owns 6,958,543 shares of the company’s stock valued at $1,133,755,000 after purchasing an additional 3,059,255 shares during the period. 92.80% of the stock is owned by hedge funds and other institutional investors.

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.